🇺🇸 FDA
Patent

US 8685396

Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

granted A61KA61K2039/505A61P

Quick answer

US patent 8685396 (Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61P, A61P31/04